HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids.

Abstract
Continuous ambulatory peritoneal dialysis is an important modality of therapy for patients with renal disease. However, peritonitis continues to be a major risk factor and is usually treated by intraperitoneal administration of antimicrobial agents. Few data are available concerning the stability of antimicrobial agents in peritoneal dialysis solution beyond 48 h. Our investigation was designed to establish the chemical and biological stability of gentamicin alone and in combination with cefazolin in peritoneal dialysis solution at 6 and 72 h by an immunoassay and by an in vitro bactericidal test against American Type Culture Collection (Rockville, Md.) strains of Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis. In addition, uninfected peritoneal dialysis effluent was inoculated with three American Type Culture Collection strains and gentamicin or imipenem. Gentamicin alone or in combination with cefazolin was not altered chemically and was bactericidal for Staphylococcus spp. but not P. aeruginosa. In contrast, imipenem was active against both Staphylococcus spp. and P. aeruginosa. Undefined factors other than inactivation of gentamicin may be responsible for the lack of bactericidal activity and treatment failure of Pseudomonas infections.
AuthorsD C Halstead, J Guzzo, J A Giardina, A E Geshan
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 33 Issue 9 Pg. 1553-6 (Sep 1989) ISSN: 0066-4804 [Print] United States
PMID2510594 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dialysis Solutions
  • Gentamicins
  • Imipenem
  • Cefazolin
Topics
  • Bacteria (drug effects)
  • Cefazolin (pharmacology)
  • Dialysis Solutions
  • Gentamicins (pharmacology)
  • Imipenem (pharmacology)
  • Microbial Sensitivity Tests
  • Pseudomonas aeruginosa (drug effects)
  • Staphylococcus aureus (drug effects)
  • Staphylococcus epidermidis (drug effects)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: